{"log_id": 4863718328096397139, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.020156, "average": 0.925496, "min": 0.392322}, "location": {"width": 780, "top": 159, "height": 48, "left": 206}, "words": "品于低CD4(<200CD淋巴细胞/mm3)及有广泛皮肤粘膜内脏疾病的与艾滋病"}, {"probability": {"variance": 0.02171, "average": 0.916834, "min": 0.369122}, "location": {"width": 341, "top": 223, "height": 34, "left": 155}, "words": "相关的卡波氏肉瘤(ADS-KS)病人"}, {"probability": {"variance": 0.0085, "average": 0.965954, "min": 0.601314}, "location": {"width": 786, "top": 259, "height": 46, "left": 199}, "words": "本品可用作一线全身化疗药物,或者用作治疗病情进展的AIDS-KS病人的二线化疗"}, {"probability": {"variance": 0.015399, "average": 0.944206, "min": 0.413573}, "location": {"width": 832, "top": 307, "height": 49, "left": 155}, "words": "药物,也可用不能耐受下列两种以上药物联合化疗的病人:长春新碱、博莱霉索和多柔比"}, {"probability": {"variance": 0.020197, "average": 0.949712, "min": 0.523448}, "location": {"width": 251, "top": 372, "height": 27, "left": 158}, "words": "早或其他环类抗生素)"}, {"probability": {"variance": 0.020619, "average": 0.924368, "min": 0.450113}, "location": {"width": 232, "top": 424, "height": 28, "left": 162}, "words": "【规格】20mg/10ml/"}, {"probability": {"variance": 4e-06, "average": 0.998489, "min": 0.994008}, "location": {"width": 138, "top": 473, "height": 26, "left": 162}, "words": "【用法与用量】"}, {"probability": {"variance": 0.000353, "average": 0.99385, "min": 0.890434}, "location": {"width": 773, "top": 507, "height": 43, "left": 198}, "words": "本品按20mgm,每2-3周一次静脉内给药,因不能排除药物蓄积和毒性增强的可能"}, {"probability": {"variance": 0.003615, "average": 0.978724, "min": 0.697818}, "location": {"width": 833, "top": 556, "height": 43, "left": 156}, "words": "故给药间隔不宜少丁10天。病人应持续治疗2~3个月以产生疗效。为保持一定的疗效,在"}, {"probability": {"variance": 0.000288, "average": 0.992464, "min": 0.947767}, "location": {"width": 183, "top": 619, "height": 27, "left": 156}, "words": "需要时应继续治疗"}, {"probability": {"variance": 0.011247, "average": 0.96212, "min": 0.433509}, "location": {"width": 780, "top": 653, "height": 46, "left": 199}, "words": "本品用250ml或500ml,5%50mg/m)葡萄糖注射液稀释后使用,静脉滴注30分钟以上"}, {"probability": {"variance": 0.013714, "average": 0.962636, "min": 0.469656}, "location": {"width": 620, "top": 707, "height": 40, "left": 198}, "words": "根据推荐剂量和病人的体表面积确定本品的剂量并按下述方法稀释"}, {"probability": {"variance": 0.004851, "average": 0.971164, "min": 0.699453}, "location": {"width": 590, "top": 756, "height": 41, "left": 201}, "words": "剂单<90mg:本品用250ml5%(50mg/ml)葡萄糖注射液稀释"}, {"probability": {"variance": 0.014712, "average": 0.87321, "min": 0.751917}, "location": {"width": 69, "top": 763, "height": 51, "left": 951}, "words": "生么"}, {"probability": {"variance": 0.006162, "average": 0.970752, "min": 0.584057}, "location": {"width": 589, "top": 804, "height": 40, "left": 201}, "words": "剂量≥90mg:本品用500ml5%(50mg/ml)葡萄糖注射液稀释"}, {"probability": {"variance": 0, "average": 0.999449, "min": 0.998227}, "location": {"width": 129, "top": 861, "height": 27, "left": 212}, "words": "使用时应注意"}, {"probability": {"variance": 0.011647, "average": 0.944959, "min": 0.615212}, "location": {"width": 248, "top": 906, "height": 31, "left": 156}, "words": "1、禁用于肌肉和皮下注射"}, {"probability": {"variance": 6.3e-05, "average": 0.995256, "min": 0.967413}, "location": {"width": 384, "top": 952, "height": 35, "left": 156}, "words": "2、禁止使用有沉淀物或其他杂质的器材"}, {"probability": {"variance": 0.009302, "average": 0.960211, "min": 0.636735}, "location": {"width": 293, "top": 1003, "height": 33, "left": 157}, "words": "3、用灭函注射器吸取适量本品"}, {"probability": {"variance": 0.008389, "average": 0.965399, "min": 0.605442}, "location": {"width": 555, "top": 1045, "height": 40, "left": 192}, "words": "由于本品中术加防腐剂或抑菌剂,故必须严格遵守无菌操作"}, {"probability": {"variance": 0.008588, "average": 0.966149, "min": 0.565919}, "location": {"width": 672, "top": 1093, "height": 37, "left": 190}, "words": "除5%葡萄糖注射液外的其他稀释剂或任何抑函剂都可能使本品产生沉淀"}, {"probability": {"variance": 0.00042, "average": 0.990143, "min": 0.905762}, "location": {"width": 650, "top": 1140, "height": 37, "left": 191}, "words": "建议将本品滴注管与5%葡萄糖静脉滴注管相连通。禁止使用在线滤器"}, {"probability": {"variance": 0.006917, "average": 0.975577, "min": 0.588391}, "location": {"width": 840, "top": 1186, "height": 43, "left": 159}, "words": "7、使用本品溶液时要谨慎,需戴手套。如果药液与皮肤或粘膜发生接触,应立即用肥皂水"}, {"probability": {"variance": 0.003744, "average": 0.967961, "min": 0.791845}, "location": {"width": 497, "top": 1241, "height": 37, "left": 193}, "words": "清洗。本品的应用和处置的方法与其他抗癌药物相同"}, {"probability": {"variance": 0.007865, "average": 0.96418, "min": 0.650505}, "location": {"width": 804, "top": 1285, "height": 41, "left": 194}, "words": "为减小滴注反应的风险,起始给约速率应不大于1mg/min。如果无滴注反应,以后的滴"}, {"probability": {"variance": 0.000356, "average": 0.994449, "min": 0.882937}, "location": {"width": 804, "top": 1332, "height": 42, "left": 194}, "words": "注可在60分钟完成。对有滴注反应的病人,滴注方法应作如下调整:总剂量的5%应在"}, {"probability": {"variance": 0.007409, "average": 0.976861, "min": 0.494205}, "location": {"width": 802, "top": 1381, "height": 42, "left": 196}, "words": "开始的15分钟缓慢滴注、如果病人可以耐受且无反应,接下来的15分钟里滴注速度可"}, {"probability": {"variance": 0.013119, "average": 0.96068, "min": 0.458937}, "location": {"width": 734, "top": 1432, "height": 39, "left": 195}, "words": "以加倍:如果仍能耐受,滴注可在接卜米的一小时内完成,总滴注时间90分钟"}, {"probability": {"variance": 0.023522, "average": 0.929939, "min": 0.448265}, "location": {"width": 346, "top": 1486, "height": 35, "left": 193}, "words": "配伍禁芯:不得与其他药物混合使用"}, {"probability": {"variance": 6e-05, "average": 0.995484, "min": 0.982089}, "location": {"width": 88, "top": 1541, "height": 24, "left": 201}, "words": "特别注意"}, {"probability": {"variance": 0.001333, "average": 0.987577, "min": 0.788485}, "location": {"width": 798, "top": 1575, "height": 40, "left": 202}, "words": "出现早期滴注反应的处理如果病人出现早期滴注反应,应立即中断滴注,预先给予"}], "language": 3}